News LabCorp - Largest Companies by Marketcap, Revenue, Net Income and Employees

Is This the Right Time to Add Labcorp Stock to Your Portfolio?

29.09.2026 11:44

LH expands specialty testing and consumer services through acquisitions, partnerships and AI, while reimbursement and cost risks remain.

Labcorp Holdings (LH) Eyes Acquisitions And Lab Tech Investment After 2026 Investor Day

23.09.2026 11:13

Labcorp Holdings (NYSE:LH) used its 2026 Investor Day to outline a push into targeted acquisitions and new lab technologies. Management emphasized capital deployment toward advanced lab management systems and expanded digital experiences for patients and providers. The company highlighted plans to integrate acquired platforms with its existing diagnostic infrastructure to streamline operations and data handling. Labcorp's renewed focus on acquisitions and digital lab tools only tells part of...

2 Small-Cap Stocks to Research Further and 1 Facing Challenges

23.09.2026 08:37

Investors looking for hidden gems should keep an eye on small-cap stocks because they’re frequently overlooked by Wall Street. Many opportunities exist in this part of the market, but it is also a high-risk, high-reward environment due to the lack of reliable analyst price targets.

Is Labcorp Holdings Stock Outperforming the Dow?

23.09.2026 06:16

Labcorp Holdings stock has outpaced the Dow this year, and analysts remain bullish about its prospects.

Truist Securities Maintains Buy on Labcorp Holdings, Raises Price Target to $365

21.09.2026 09:03

Truist Securities analyst David Macdonald maintains Labcorp Holdings (NYSE:LH) with a Buy and raises the price target from $350 to $365.

2 of Wall Street’s Favorite Stocks to Target This Week and 1 Facing Challenges

16.09.2026 07:08

Wall Street has set ambitious price targets for the stocks in this article. While this suggests attractive upside potential, it’s important to remain skeptical because analysts face institutional pressures that can sometimes lead to overly optimistic forecasts.

Labcorp Holdings Inc. (LH) Analyst/Investor Day Transcript

11.09.2026 04:17

Labcorp Holdings Inc. (LH) Analyst/Investor Day September 10, 2026 9:00 AM EDTCompany ParticipantsDewey Steadman - Senior Vice President of Investor...

Moonwalk Biosciences Announces $70 Million Series B: NYSE Content Update

09.09.2026 12:55

The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insights before trading begins.

Is Labcorp Stock a Buy as Growth Improves but Valuation Stays Rich?

10.08.2026 14:44

LH enters late 2026 with stronger growth, margin gains and raised guidance, but a rich valuation and cost risks support a measured view.

PODD's Q2 Earnings Top Estimates, FY'26 Sales View Cut, Stock Down

10.08.2026 13:22

Insulet's Q2 results beat estimates on strong Omnipod demand and wider margins, but its 2026 revenue outlook takes a hit.

Labcorp Announces FDA Approval of Companion Diagnostic Supporting Patients with Advanced Melanoma

10.08.2026 11:00

Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, today announced that the U.S. Food and Drug Administration (FDA) has approved Labcorp's PGDx elio® tissue complete CDx as a companion diagnostic to help identify patients with advanced melanoma with certain BRAF variants who may benefit from treatment with FDA-approved targeted therapiesi.

CVS Health Q2 Earnings and Revenues Top Estimates, Stock Climbs

05.08.2026 14:20

CVS beats Q2 earnings and revenue estimates as stronger segment performance lifts results and prompts raised 2026 guidance, sending shares higher.

Labcorp Launches FDA-Approved PTEN Companion Diagnostic for Prostate Cancer

04.08.2026 11:00

Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced the nationwide availability of Roche's VENTANA® PTEN (SP218) RxDx Assay, the first immunohistochemistry (IHC) companion diagnostic test approved by the U.S. Food and Drug Administration (FDA) to determine PTEN protein loss, also known as PTEN deficiency, in tumors of patients with prostate adenocarcinoma. The assay helps identify patients who may be eligible for treatment with AstraZeneca's TRUQAP®

Labcorp Launches FDA-Approved PTEN Companion Diagnostic for Prostate Cancer

04.08.2026 11:00

Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced the nationwide availability of Roche's VENTANA® PTEN (SP218) RxDx Assay, the first immunohistochemistry (IHC) companion diagnostic test approved by the U.S. Food and Drug Administration (FDA) to determine PTEN protein loss, also known as PTEN deficiency, in tumors of patients with prostate adenocarcinoma. The assay helps identify patients who may be eligible for treatment with AstraZeneca's TRUQAP®

Labcorp (LH) Q2 2026 Earnings Call Transcript

04.08.2026 00:16

Specialty testing and Central Labs fueled revenue growth and margin expansion.

Is DGX Stock Worth Buying After Its Strong 2026 Earnings Momentum?

31.07.2026 14:06

Quest Diagnostics' earnings beat, raised 2026 outlook and broad testing demand support momentum, but valuation, debt and margin pressure temper the buy case.

Labcorp Q2 Earnings Call Highlights

31.07.2026 12:03

Labcorp (NYSE:LH) reported second-quarter 2026 revenue growth, margin expansion and higher adjusted earnings, prompting the laboratory services company to raise the midpoint of its full-year revenue and adjusted EPS guidance. Revenue rose 5.8% year over year to $3.7 billion, while adjusted operatin